| Data |
Ora |
Fonte |
Titolo |
|---|
| 31/5/2024 | 14:36 | GLOBE | Data and Safety Monitoring Board Approves Simultaneous.. |
| 29/5/2024 | 13:15 | GLOBE | Ocugen to Present at BIO International Convention 2024 |
| 28/5/2024 | 22:05 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 28/5/2024 | 13:02 | GLOBE | Ocugen Set to Join Russell 3000® Index Effective June 28,.. |
| 20/5/2024 | 13:00 | GLOBE | Ocugen Announces CSO to Present on Modifier Gene Therapy.. |
| 17/5/2024 | 22:30 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
| 15/5/2024 | 12:30 | GLOBE | Ocugen Announces Dosing Completion of Subjects with.. |
| 14/5/2024 | 21:54 | EDGAR2 | Form 8-K - Current report |
| 14/5/2024 | 14:00 | GLOBE | Ocugen Provides Business Update with First Quarter 2024.. |
| 14/5/2024 | 13:18 | IHMARKETNEWS | US Futures Remain Steady Amid Wall Street Caution Ahead of.. |
| 14/5/2024 | 12:32 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 10/5/2024 | 22:15 | EDGAR2 | Form 8-A12G - Registration of securities [Section 12(g)] |
| 10/5/2024 | 22:14 | EDGAR2 | Form 8-K - Current report |
| 10/5/2024 | 22:05 | GLOBE | Ocugen Announces Distribution of Series C Preferred Stock to.. |
| 10/5/2024 | 13:45 | GLOBE | Ocugen to Present at May 2024 Investor Conferences |
| 03/5/2024 | 13:30 | GLOBE | Ocugen to Host Conference Call on Tuesday, May 14 at 8:30.. |
| 02/5/2024 | 13:15 | GLOBE | Ocugen Announces CSO to Present on Modifier Gene Therapy at.. |
| 29/4/2024 | 12:45 | GLOBE | Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data.. |
| 26/4/2024 | 15:05 | GLOBE | UPDATE -- Ocugen to Present on Modifier Gene Therapy.. |
| 26/4/2024 | 12:30 | GLOBE | Ocugen to Present on Modifier Gene Therapy Platform at.. |
| 19/4/2024 | 13:13 | GLOBE | Ocugen Announces Dosing Completion of Subjects with.. |
| 12/4/2024 | 13:30 | GLOBE | Ocugen to Participate in Fireside Chat at the Emerging.. |
| 10/4/2024 | 13:02 | GLOBE | Ocugen, Inc. Announces Positive Scientific Advice from the.. |
| 08/4/2024 | 12:30 | GLOBE | Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment.. |
| 05/4/2024 | 13:02 | GLOBE | Ocugen Announces Positive Data and Safety Monitoring Board.. |
| 02/4/2024 | 14:00 | GLOBE | Ocugen Provides Business Update with Certain Financials for.. |
| 02/4/2024 | 00:08 | GLOBE | Ocugen Announces Positive Data and Safety Monitoring Board.. |
| 01/4/2024 | 23:43 | GLOBE | Ocugen to Host Conference Call on Tuesday, April 2 at 8:30.. |
| 18/3/2024 | 11:30 | GLOBE | Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical.. |
| 13/3/2024 | 13:00 | GLOBE | Ocugen, Inc. Announces Dosing Completion of Subjects with.. |
| 06/3/2024 | 13:30 | GLOBE | Ocugen to Present at Investing in Cures Summit |
| 28/2/2024 | 14:00 | GLOBE | Ocugen Clinical Showcase Webcast Now Available |
| 26/2/2024 | 14:30 | GLOBE | Ocugen Chairman and CEO to present at Abu Dhabi Family.. |
| 22/2/2024 | 22:05 | GLOBE | Ocugen, Inc. Announces Dosing Completion of Subjects with.. |
| 21/2/2024 | 22:05 | GLOBE | Ocugen to Present at 2024 BIO CEO & Investor Conference |
| 21/2/2024 | 17:22 | EDGAR2 | Form 8-K - Current report |
| 14/2/2024 | 13:30 | GLOBE | Ocugen to Host Clinical Showcase in New York City.. |
| 31/1/2024 | 14:00 | GLOBE | Ocugen to Present at Pharma Market Research Conference |
| 16/1/2024 | 13:30 | GLOBE | Ocugen, Inc. Announces Bob Smith Joins Business Advisory.. |
| 08/1/2024 | 12:05 | EDGAR2 | Form 8-K - Current report |
| 05/1/2024 | 22:47 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 05/1/2024 | 22:47 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 04/1/2024 | 23:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 04/1/2024 | 23:04 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 22/12/2023 | 21:09 | EDGAR2 | Form 8-K - Current report |
| 21/12/2023 | 12:30 | GLOBE | Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier.. |
| 19/12/2023 | 13:30 | GLOBE | Ocugen Announces OCU400 Receives Regenerative Medicine.. |
| 13/12/2023 | 13:30 | GLOBE | Ocugen, Inc. Announces First Patient Dosed in Phase 1/2.. |
| 29/11/2023 | 13:30 | GLOBE | Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’.. |
| 10/11/2023 | 13:30 | GLOBE | Ocugen, Inc. Announces First Patient Dosed in Phase 1/2.. |
Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
